GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » CXI Healthcare Technology Group Ltd (XKRX:900120) » Definitions » Revenue

CXI Healthcare Technology Group (XKRX:900120) Revenue : ₩66,324 Mil (TTM As of Dec. 2024)


View and export this data going back to 2010. Start your Free Trial

What is CXI Healthcare Technology Group Revenue?

CXI Healthcare Technology Group's revenue for the three months ended in Dec. 2024 was ₩9,176 Mil. Its revenue for the trailing twelve months (TTM) ended in Dec. 2024 was ₩66,324 Mil. CXI Healthcare Technology Group's Revenue per Share for the three months ended in Dec. 2024 was ₩30.35. Its Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2024 was ₩220.31.

Warning Sign:

CXI Healthcare Technology Group Ltd revenue per share has been in decline for the last 5 years.

During the past 12 months, the average Revenue per Share Growth Rate of CXI Healthcare Technology Group was -44.50% per year. During the past 3 years, the average Revenue per Share Growth Rate was -33.80% per year. During the past 5 years, the average Revenue per Share Growth Rate was -20.90% per year. During the past 10 years, the average Revenue per Share Growth Rate was -20.40% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get other companies' revenue growth rate using Revenue per Share data.

During the past 13 years, CXI Healthcare Technology Group's highest 3-Year average Revenue per Share Growth Rate was 19.70% per year. The lowest was -33.80% per year. And the median was -10.50% per year.


CXI Healthcare Technology Group Revenue Historical Data

The historical data trend for CXI Healthcare Technology Group's Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

CXI Healthcare Technology Group Revenue Chart

CXI Healthcare Technology Group Annual Data
Trend Jun15 Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23 Jun24
Revenue
Get a 7-Day Free Trial Premium Member Only Premium Member Only 63,405.59 104,592.68 101,376.33 71,617.39 69,419.65

CXI Healthcare Technology Group Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 10,385.83 12,887.49 26,057.68 18,203.55 9,175.50

Competitive Comparison of CXI Healthcare Technology Group's Revenue

For the Drug Manufacturers - Specialty & Generic subindustry, CXI Healthcare Technology Group's Revenue, along with its competitors' market caps and Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


CXI Healthcare Technology Group's Revenue Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, CXI Healthcare Technology Group's Revenue distribution charts can be found below:

* The bar in red indicates where CXI Healthcare Technology Group's Revenue falls into.


;
;

CXI Healthcare Technology Group Revenue Calculation

Also referred as sales, revenue is income that a company receives from its normal business activities, usually from the sale of goods and services to customers. Revenue is often referred to as the "top line" due to its position on the income statement at the very top.

Revenue for the trailing twelve months (TTM) ended in Dec. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₩66,324 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


CXI Healthcare Technology Group  (XKRX:900120) Revenue Explanation

In ranking the predictability, companies with more consistent revenue and earnings growth are ranked high with predictability.

Peter Lynch categorized companies according to their revenue growth:


Slow Grower: Inflation < 10-Year Revenue Growth Rate < 10%:
Stalwart: 10% < 10-Year Revenue Growth Rate < 20%:
Fast Grower: 10-Year Revenue Growth Rate > 20%:

His favorite companies are stalwart, those growing between 10-20% a year.

Companies in cyclical industries may see their revenue fluctuate wildly in good years and bad years.


Be Aware

Revenue can be manipulated by changing the way how revenue is booked. Companies may book sales before the payment is received, or before the revenue is fully earned. These will be added to balance sheet items such as account payable or account receivables.


CXI Healthcare Technology Group Revenue Related Terms

Thank you for viewing the detailed overview of CXI Healthcare Technology Group's Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


CXI Healthcare Technology Group Business Description

Traded in Other Exchanges
N/A
Address
Century Yard, Cricket Square, PO Box 902, 3rd Floor, Grand Cayman, CYM, KY1-1103
CXI Healthcare Technology Group Ltd is a food manufacturing and distribution company. It operates through subsidiaries that manufacture nutritional supplements. The company's products include Traditional Chinese medicines in the form of a capsule, drinks, and tea. All of its products are marketed only in China.

CXI Healthcare Technology Group Headlines

No Headlines